Shim Clinic Logo

Benign Prostatic Hyperplasia, Singapore - Shim Clinic

Benign prostatic hyperplasia


Latest News

7 medtech stories we missed this week: July 7, 2017
Sat, 08 Jul 2017 00:16:26 +0800 | Mass Device
[Image from unsplash.com]From EnvisionTEC’s FDA approval to InVivo Therapeutics adding a new clinical site, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. EnvisionTEC wins FDA nod for 3D printing E-Denture material EnvisionTEC announced in a June 30 press release that it has received FDA approval for its E-Denture material for 3D printing dentures. The company already has the E-Dent 100 and 400 materials approved for the printing of restorations that simulate teeth. The new approval makes EnvisionTEC the only 3D printing company worldwide that has a complete digital denture workflow solution. E-Denture will have a limited distribution in the third quarter and will be available in four natural shades. 2. Life Spine launches Osseo-Loc pro...

Tamsulosin and Naftopidil Offer Similar Benefits in BPH Tamsulosin and Naftopidil Offer Similar Benefits in BPH
Sat, 01 Jul 2017 01:39:51 +0800 | Medscape Medical News Headlines
Bladder storage symptoms associated with benign prostatic hyperplasia (BPH) improve to a similar extent with tamsulosin and naftopidil treatment, researchers from South Korea report.Reuters Health Information (Source: Medscape Medical News Headlines)

FDA grants de novo clearance for Merit Medical ’ s Embosphere
Fri, 23 Jun 2017 20:36:03 +0800 | Mass Device
Merit Medical (NSDQ:MMSI) said yesterday that its Embosphere device won expanded de novo clearance from the  to treat benign prostatic hyperplasia. The federal safety watchdog’s clearance means Embosphere can be used in prostatic artery embolization  procedures to treat BPH. “Merit’s Embosphere is the first embolic agent to receive FDA 513(f)(2) classification for prostatic artery embolization, providing a non-surgical treatment option for millions of men who suffer from BPH,” chairman & CEO Fred Lampropoulos said in prepared remarks. The device is designed to occlude the prostatic arteries to shrink the prostate and improve BPH symptoms, South Jordan, Utah-based Merit said. The post FDA grants de novo clearance for Merit Medical’s Embosphere appeared...

Popular prostate drug linked to serious side effects
Thu, 22 Jun 2017 11:00:00 +0800 | EurekAlert! - Medicine and Health
(Boston University Medical Center) Treatment of benign prostatic hyperplasia (BPH) with the commonly prescribed Avodart (Dutsteride) may put men at an increased risk for diabetes, elevated cholesterol levels, non-alcoholic fatty liver disease (NAFLD) and worsening erectile dysfunction. (Source: EurekAlert! - Medicine and Health)

2017 Eureka! Innovation award winner: NxThera Inc.
Wed, 21 Jun 2017 13:00:00 +0800 | bizjournals.com Health Care:Biotechnology headlines
Industry category: Health Care Technology Organization size: Small — revenue less than $50 million Eureka! idea: Uses water vapor to treat endourological diseases that affect millions of men, with a safe, effective and fast procedure What the judges said:"The team is great. It's a slick treatment option — killing cells in the gentle st way possible." Benign prostatic hyperplasia, an enlargement of the prostate gland, affects 12 million men in the United States, with nearly 800,000 new diagnoses… (Source: bizjournals.com Health Care:Biotechnology headlines)

7 medtech stories we missed this week: May 26, 2017
Fri, 26 May 2017 23:08:39 +0800 | Mass Device
[Image from unsplash.com]From Merck’s new licensing agreement to surgical study data being touted, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Merck inks exclusive licensing agreement for Alzheimer’s antibody Merck announced in a May 25 press release that it has entered an exclusive worldwide license agreement with Teijin Pharma. The licensing agreement is going to help with the development, manufacture and commercialization of an investigation preclinical antibody candidate that targets the protein tau. Merck will have exclusive worldwide rights to develop, manufacture and commercialize the anti-tau antibody while Teijin Pharma will receive an upfront payment for development, regulatory and sales milestone payments. Teijin Pharma ...

7 medtech stories we missed this week: May 19, 2017
Sat, 20 May 2017 02:15:42 +0800 | Mass Device
[Image from unsplash.com]From FDA clearances to touting study data, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. XpandOrtho wins FDA 510(k) clearance XpandOrtho announced in a May 17 press release that it has received FDA 510(k) clearance for its electronic soft tissue balancing instrument for total knee replacement surgery. The sterile-packaged wireless disposable device uses miniature sensors and actuators to balance knee joints during full-range motions. Using constant pressure bellows systems, the device communicates with a display for multiaxial balance and selection of thickness and tibial component. 2. Visionsense goes after Novadaq patent Visionsense has filed an IPR with the USPTO for its Novadaq Technologies’ U.S. patent, according ...

Enlarged Prostate ( BPH, Benign Prostatic Hyperplasia)
Thu, 18 May 2017 14:00:00 +0800 | MedicineNet Mens Health General
Title: Enlarged Prostate ( BPH, Benign Prostatic Hyperplasia)Category: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 5/18/2017 12:00:00 AM (Source: MedicineNet Mens Health General)

Enlarged Prostate (BPH, Benign Prostatic Hyperplasia)
Thu, 18 May 2017 14:00:00 +0800 | MedicineNet Mens Health General
Title: Enlarged Prostate (BPH, Benign Prostatic Hyperplasia)Category: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 5/18/2017 12:00:00 AM (Source: MedicineNet Mens Health General)

MassDevice.com +5 | The top 5 medtech stories for May 17, 2017
Thu, 18 May 2017 02:00:44 +0800 | Mass Device
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. 10 innovative diagnostic tests to combat diseases Medtech is seeing new exciting developments in the field of medical diagnostics, with recent innovations allowing for faster disease diagnosis than ever before. We cover 10 diagnostic tests that could change how quickly we can catch dangerous diseases. Read more   4. Robotic surgery: Here’s everything you need to know Robotic surg...


Related Concepts


Private & Confidential Service